These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 33659867)

  • 21. The influence of water on the stability of lyophilized formulations with inositol and mannitol as excipients.
    Terakita A; Matsunaga H; Handa T
    Chem Pharm Bull (Tokyo); 2009 May; 57(5):459-63. PubMed ID: 19420775
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Selective detection of active pharmaceutical ingredients in tablet formulations using solid-state NMR spectroscopy.
    Hong YL; Manjunatha Reddy GN; Nishiyama Y
    Solid State Nucl Magn Reson; 2020 Apr; 106():101651. PubMed ID: 32058901
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Studying Excipient Modulated Physical Stability and Viscosity of Monoclonal Antibody Formulations Using Small-Angle Scattering.
    Xu AY; Castellanos MM; Mattison K; Krueger S; Curtis JE
    Mol Pharm; 2019 Oct; 16(10):4319-4338. PubMed ID: 31487466
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Application of NMR and Chemometric Analyses to Better Understand the Quality Attributes in pH and Thermally Degraded Monoclonal Antibodies.
    Beaumont VA; Liu L; Shi H; Rouse JC; Kim HY
    Pharm Res; 2023 Oct; 40(10):2457-2467. PubMed ID: 37798537
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Quantification of Silicone Oil and Its Degradation Products in Aqueous Pharmaceutical Formulations by
    Malmstrøm J
    J Pharm Sci; 2019 Apr; 108(4):1512-1520. PubMed ID: 30471289
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Formulation Excipients and Their Role in Insulin Stability and Association State in Formulation.
    Maikawa CL; Nguyen LT; Mann JL; Appel EA
    Pharm Res; 2022 Nov; 39(11):2721-2728. PubMed ID: 35978148
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Secondary Packages cannot Protect Liquid Biopharmaceutical Formulations from Dropping-Induced Degradation.
    Fang WJ; Liu JW; Gao H; Qian YC; Gao JQ; Wang H
    Pharm Res; 2021 Aug; 38(8):1397-1404. PubMed ID: 34282500
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Analysis of biopharmaceutical formulations by Time Domain Nuclear Magnetic Resonance (TD-NMR) spectroscopy: A potential method for detection of counterfeit biologic pharmaceuticals.
    Akhunzada Z; Wu Y; Haby T; Jayawickrama D; McGeorge G; La Colla M; Bernstein J; Semones M; Abraham A
    J Pharm Sci; 2021 Jul; 110(7):2765-2770. PubMed ID: 33745914
    [No Abstract]   [Full Text] [Related]  

  • 29. Stable High-Concentration Monoclonal Antibody Formulations Enabled by an Amphiphilic Copolymer Excipient.
    Klich JH; Kasse CM; Mann JL; Huang Y; d'Aquino AI; Grosskopf AK; Baillet J; Fuller GG; Appel EA
    Adv Ther (Weinh); 2023 Jan; 6(1):. PubMed ID: 36684707
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification and characterization of chemical and physical stability of insulin formulations utilizing degraded glycerol after repeated use and storage.
    Sun MF; Xu Y; Yuan JJ; Fang WJ
    Eur J Pharm Biopharm; 2022 Aug; 177():147-156. PubMed ID: 35779744
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characterization of Protein-Excipient Microheterogeneity in Biopharmaceutical Solid-State Formulations by Confocal Fluorescence Microscopy.
    Koshari SH; Ross JL; Nayak PK; Zarraga IE; Rajagopal K; Wagner NJ; Lenhoff AM
    Mol Pharm; 2017 Feb; 14(2):546-553. PubMed ID: 28094996
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Stability of buffer-free freeze-dried formulations: A feasibility study of a monoclonal antibody at high protein concentrations.
    Garidel P; Pevestorf B; Bahrenburg S
    Eur J Pharm Biopharm; 2015 Nov; 97(Pt A):125-39. PubMed ID: 26455339
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Analysis methods of polysorbate 20: A new method to assess the stability of polysorbate 20 and established methods that may overlook degraded polysorbate 20.
    Khossravi M; Kao YH; Mrsny RJ; Sweeney TD
    Pharm Res; 2002 May; 19(5):634-9. PubMed ID: 12069166
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Investigation of freeze/thaw-related quality attributes of a liquid biopharmaceutical formulation: the role of saccharide excipients.
    Zhou R; Schlam RF; Yin S; Gandhi RB; Adams ML
    PDA J Pharm Sci Technol; 2012; 66(3):221-35. PubMed ID: 22634588
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Near Infrared Spectroscopy as a PAT tool for monitoring and control of protein and excipient concentration in ultrafiltration of highly concentrated antibody formulations.
    Thakur G; Hebbi V; Rathore AS
    Int J Pharm; 2021 May; 600():120456. PubMed ID: 33711473
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of drying method and excipient on the structure and physical stability of protein solids: Freeze drying vs. spray freeze drying.
    Mutukuri TT; Wilson NE; Taylor LS; Topp EM; Zhou QT
    Int J Pharm; 2021 Feb; 594():120169. PubMed ID: 33333176
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Higher-Order Structure Characterization of Pharmaceutical Proteins by 2D Nuclear Magnetic Resonance Methyl Fingerprinting.
    Haxholm GW; Petersen BO; Malmstrøm J
    J Pharm Sci; 2019 Sep; 108(9):3029-3035. PubMed ID: 31082403
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Selective Stabilization and Destabilization of Protein Domains in Tissue-Type Plasminogen Activator Using Formulation Excipients.
    Robinson MJ; Matejtschuk P; Longstaff C; Dalby PA
    Mol Pharm; 2019 Feb; 16(2):744-755. PubMed ID: 30565948
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In Situ Characterization of the Microstructural Evolution of Biopharmaceutical Solid-State Formulations with Implications for Protein Stability.
    Koshari SHS; Nayak PK; Burra S; Zarraga IE; Rajagopal K; Liu Y; Wagner NJ; Lenhoff AM
    Mol Pharm; 2019 Jan; 16(1):173-183. PubMed ID: 30484319
    [TBL] [Abstract][Full Text] [Related]  

  • 40. NMR based quality evaluation of mAb therapeutics: A proof of concept higher order structure biosimilarity assessment of trastuzumab biosimilars.
    Joshi S; Khatri LR; Kumar A; Rathore AS
    J Pharm Biomed Anal; 2022 May; 214():114710. PubMed ID: 35290923
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.